BDMD Statistics
Total Valuation
BDMD has a market cap or net worth of $42.23 million. The enterprise value is $62.29 million.
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BDMD has 36.73 million shares outstanding. The number of shares has increased by 9.96% in one year.
| Current Share Class | 36.73M |
| Shares Outstanding | 36.73M |
| Shares Change (YoY) | +9.96% |
| Shares Change (QoQ) | +20.87% |
| Owned by Insiders (%) | 49.82% |
| Owned by Institutions (%) | 1.35% |
| Float | 10.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.94 |
| Forward PS | n/a |
| PB Ratio | 0.86 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | 67.75 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.63.
| Current Ratio | 1.71 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 17.10 |
| Debt / FCF | n/a |
| Interest Coverage | -0.32 |
Financial Efficiency
Return on equity (ROE) is -8.03% and return on invested capital (ROIC) is -0.25%.
| Return on Equity (ROE) | -8.03% |
| Return on Assets (ROA) | -0.20% |
| Return on Invested Capital (ROIC) | -0.25% |
| Return on Capital Employed (ROCE) | -0.54% |
| Revenue Per Employee | $222,797 |
| Profits Per Employee | -$22,173 |
| Employee Count | 143 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.27 |
Taxes
In the past 12 months, BDMD has paid $1.57 million in taxes.
| Income Tax | 1.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.63% in the last 52 weeks. The beta is -1.07, so BDMD's price volatility has been lower than the market average.
| Beta (5Y) | -1.07 |
| 52-Week Price Change | -82.63% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 29.79 |
| Average Volume (20 Days) | 75,269 |
Short Selling Information
The latest short interest is 205,875, so 0.56% of the outstanding shares have been sold short.
| Short Interest | 205,875 |
| Short Previous Month | 186,241 |
| Short % of Shares Out | 0.56% |
| Short % of Float | 1.93% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
In the last 12 months, BDMD had revenue of $31.86 million and -$3.17 million in losses. Loss per share was -$0.12.
| Revenue | 31.86M |
| Gross Profit | 27.70M |
| Operating Income | -224,535 |
| Pretax Income | -1.44M |
| Net Income | -3.17M |
| EBITDA | 919,415 |
| EBIT | -224,535 |
| Loss Per Share | -$0.12 |
Full Income StatementBalance Sheet
The company has $2.50 million in cash and $22.56 million in debt, with a net cash position of -$20.06 million or -$0.55 per share.
| Cash & Cash Equivalents | 2.50M |
| Total Debt | 22.56M |
| Net Cash | -20.06M |
| Net Cash Per Share | -$0.55 |
| Equity (Book Value) | 35.62M |
| Book Value Per Share | 1.34 |
| Working Capital | 25.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.55 million and capital expenditures -$2.41 million, giving a free cash flow of -$7.96 million.
| Operating Cash Flow | -5.55M |
| Capital Expenditures | -2.41M |
| Free Cash Flow | -7.96M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
Gross margin is 86.94%, with operating and profit margins of -0.70% and -9.95%.
| Gross Margin | 86.94% |
| Operating Margin | -0.70% |
| Pretax Margin | -4.52% |
| Profit Margin | -9.95% |
| EBITDA Margin | 2.89% |
| EBIT Margin | -0.70% |
| FCF Margin | n/a |
Dividends & Yields
BDMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.96% |
| Shareholder Yield | -9.96% |
| Earnings Yield | -7.51% |
| FCF Yield | -18.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BDMD has an Altman Z-Score of 3.27.
| Altman Z-Score | 3.27 |
| Piotroski F-Score | n/a |
